XML 35 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Intangible Assets
 12 Months Ended
Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets
Note 4. Intangible Assets
Goodwill
The Company has three reporting units: CooperVision and within the CooperSurgical segment, Office/Surgical and Fertility, reflecting the current way the Company manages its business. There was no impairment of goodwill in its reporting units in fiscal 2022, 2021, and 2020.
(In millions)CooperVisionCooperSurgicalTotal
Balance at October 31, 2021$1,841.0 $733.0 $2,574.0 
Net additions0.9 1,183.9 1,184.8 
Foreign currency translation adjustment(131.6)(17.5)(149.1)
Balance at October 31, 2022$1,710.3 $1,899.4 $3,609.7 

Of the October 31, 2022 goodwill balance, $214.1 million for CooperSurgical and $22.4 million for CooperVision is expected to be deductible for tax purposes. Of the October 31, 2021 goodwill balance, $137.2 million for CooperSurgical and $24.6 million for CooperVision was expected to be deductible for tax purposes.
Other Intangible Assets
 October 31, 2022 October 31, 2021
(In millions)Gross
Carrying
Amount		Accumulated
Amortization		Gross
Carrying
Amount		Accumulated
Amortization
Weighted Average Amortization Period (in years)
Intangible assets with definite lives:
Trademarks$209.6 $62.4 $156.7 $49.1 15
Composite intangible asset1,061.9 354.0 1,061.8 283.2 15
Technology504.1 317.5 513.0 287.9 12
Customer relationships1,092.7 287.0 378.4 240.1 19
License and distribution rights and other50.7 23.8 33.4 21.6 11
2,919.0 $1,044.7 2,143.3 $881.9 16
Less: accumulated amortization and translation1,044.7 881.9 
Intangible assets with definite lives, net$1,874.3 $1,261.4 
Intangible assets with indefinite lives, net (1)
10.8 10.1 
Total other intangibles, net$1,885.1 $1,271.5 
(1) Intangible assets with indefinite lives include technology and trademarks.
Balances include foreign currency translation adjustments.
Intangible assets with definite lives are amortized over the estimated useful life of the assets. As of October 31, 2022, the estimate of future amortization expenses for intangible assets with definite lives is as follows:
Fiscal years:(In millions)
2023$183.2 
2024179.2 
2025169.3 
2026162.0 
Thereafter1,180.6 
Total remaining amortization for intangible assets with definite lives$1,874.3 
The Company considered the impact on its near and long-term forecasts from the general deterioration of economic and market conditions as a result of higher inflation, regional and global conflict, supply chain disruption, and the ongoing disruptions of the COVID-19 pandemic and determined that it was not more likely than not that the fair value of reporting units or relevant asset groups was below carrying amounts. Therefore, the Company determined that there was no impairment to either its definite-lived or indefinite-lived intangible assets during fiscal 2022, 2021 and 2020. There was an immaterial impairment charge related to our exit from the contact lens care business.